NIZZA MAGUIGAD: Open Payments
NPI 1851693584 · BARTLETT, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,944 in 68 payments from 7 companies in 2025. Trend: 2023 $864 · 2024 $1,055 · 2025 $2,944
Consulting: $1,590Food & beverage: $1,354
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 30 | $2,272 |
| Lilly USA, LLC | 15 | $303 |
| Currax Pharmaceuticals LLC | 17 | $177 |
| Hologic Sales and Service, LLC | 3 | $129 |
| Boston Scientific Corporation | 1 | $26 |
| VIVUS LLC | 1 | $21 |
| SHIELD THERAPEUTICS INC | 1 | $16 |
Products named: Wegovy, CONTRAVE, MOUNJARO, ZEPBOUND, Ozempic, NOVASURE, APOLLO ESG System, MYOSURE TISSUE REMOVAL DEVICE.
Industry payments across IL — which companies pay providers there.
